Search

Search Results
Results 9671 - 9680 of 10234 for Brain Cancer
  • Tripacel
    Drug - 8 May 2026
    Consumer Medicine Information (CMI) about Tripacel intended for persons living in Australia.
  • Adacel Polio
    Drug - 8 May 2026
    Consumer Medicine Information (CMI) about Adacel Polio intended for persons living in Australia.
  • Evoltra
    Drug - 5 May 2026
    Consumer Medicine Information (CMI) about Evoltra intended for persons living in Australia.
  • Multi-transporter models for blood-brain barrier studies
    Health - 23 Apr 2026
    Explore how advanced multi-transporter models improve understanding of drug transport across the blood-brain barrier in preclinical research.
  • Clopixol
    Drug - 14 Apr 2026
    Consumer Medicine Information (CMI) about Clopixol intended for persons living in Australia.
  • Cytarabine Injection
    Drug - 8 Apr 2026
    Consumer Medicine Information (CMI) about Cytarabine Injection intended for persons living in Australia.
  • DBL Cytarabine
    Drug - 3 Apr 2026
    Consumer Medicine Information (CMI) about DBL Cytarabine intended for persons living in Australia.
  • Selective PARP1 inhibitor discovery driven by translational modeling
    Health - 19 Mar 2026
    Translational research strategies enable identification of selective PARP1 inhibitors.
  • Red Light Therapy: How Light Improves Cellular Energy and Repair
    Health - 15 Mar 2026
    Discover how targeted red and near-infrared light therapies influence mitochondrial biology, cellular repair pathways, and emerging clinical treatments across multiple health systems.
  • Inrebic
    Drug - 13 Mar 2026
    Consumer Medicine Information (CMI) about Inrebic intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback